Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for venous thrombosis in cancer patients (CAP)
NCT02581176Phase 4Completed
- Start
- Apr 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in venous thrombosis. Started Apr 2016; status: completed.
02
Drugs
apixaban
03
Conditions
venous thrombosis
Beyond the preview
Go deeper on NCT02581176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02581176.